COL4A6 Gene Deafness X-linked type 6 Genetic Test
Test Name: COL4A6 Gene Deafness X-linked type 6 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Ear Nose Throat Disorders
Doctor: ENT Doctor
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS14
Test Details: Deafness, X-linked type 6 is a genetic disorder that is caused by mutations in the COL4A6 gene. This gene provides instructions for making a protein called collagen type IV alpha-6 chain, which is an important component of basement membranes in various tissues, including the inner ear. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously and identify any mutations or variations that may be present. In the case of Deafness, X-linked type 6, an NGS genetic test can be performed to specifically analyze the COL4A6 gene for any mutations or variations that may be responsible for the condition. The NGS genetic test for COL4A6 gene deafness involves obtaining a DNA sample, usually through a blood or saliva sample, from the individual undergoing testing. The DNA is then sequenced using advanced sequencing technologies to identify any changes or mutations in the COL4A6 gene. The results of the NGS genetic test can help diagnose individuals with Deafness, X-linked type 6 by identifying the specific genetic mutation responsible for the condition. This information can be useful for understanding the inheritance pattern, providing genetic counseling, and potentially guiding treatment options or interventions for affected individuals.
Test Name | COL4A6 Gene Deafness X-linked type 6 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Ear Nose Throat Disorders |
Doctor | ENT Doctor |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS14 |
Test Details |
Deafness, X-linked type 6 is a genetic disorder that is caused by mutations in the COL4A6 gene. This gene provides instructions for making a protein called collagen type IV alpha-6 chain, which is an important component of basement membranes in various tissues, including the inner ear. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously and identify any mutations or variations that may be present. In the case of Deafness, X-linked type 6, an NGS genetic test can be performed to specifically analyze the COL4A6 gene for any mutations or variations that may be responsible for the condition. The NGS genetic test for COL4A6 gene deafness involves obtaining a DNA sample, usually through a blood or saliva sample, from the individual undergoing testing. The DNA is then sequenced using advanced sequencing technologies to identify any changes or mutations in the COL4A6 gene. The results of the NGS genetic test can help diagnose individuals with Deafness, X-linked type 6 by identifying the specific genetic mutation responsible for the condition. This information can be useful for understanding the inheritance pattern, providing genetic counseling, and potentially guiding treatment options or interventions for affected individuals. |